Trial site
Erzsebet Gondozohaz Kft.
- 14running trials
- 19closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Conditions
- COPD16 trials
- Asthma13 trials
- Obesity3 trials
- Obstructive sleep apnoea2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Stroke1 trial
- Phase
- Phase 320 trials
- Phase 212 trials
- Phase 2/31 trial
- Status
- Completed19 trials
- Recruiting9 trials
- Active, not recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca8 trials
- Sanofi5 trials
- Chiesi Farmaceutici S.p.A.4 trials
- Amgen Inc.3 trials
- Pfizer2 trials
- and 11 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD5 recruiting
- Asthma3 recruiting
- Obesity2 recruiting
- Obstructive sleep apnoea2 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Completed
Completed
Completed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026